March 2015 FDA Recall Drug by Qualitest Pharmaceuticals
D00432-2015 - Failed Impurities/Degradation Specifications

This Class III drug recall was voluntarily initiated by Qualitest Pharmaceuticals on March 25, 2015 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D00432-2015

Reason for Recall
Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.
Initiated
03-25-2015
Reported
04-15-2015
Quantity
36,732 units

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Qualitest Pharmaceuticals
PROMETHAZINE VC WITH CODEINE SYRUP, EACH 5 ml contains: Codeine Phosphate 10 mg, Promethazine Hydrochloride 6.25 mg, Phenylephrine Hydrochloride 5 mg, alcohol 7%, (a) 4 fl oz bottle (NDC 0603-1588-54) and (b) 16 fl oz bottle (NDC 0603-1588-58) Rx only, Manufactured for QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811.

Batch or Lot Expiration Information

Lot# : (a) L073D14A, Exp 07/31/15.
Lot# : (b) L073D14B, Exp 07/31/15; 0000002247, Exp 03/31/16; L063B14A, Exp 05/31/15